Pharma

FDA panel to weigh Myozyme expansion

By Tracy Staton Oct 20, 2008 10:27am

Pharma

The FDA questions whether a study submitted by Genzyme is strong enough to merit expanded approval of a drug to treat a rare illness known as Pompe disease; the drug, Myozyme, is up for advisory committee discussion tomorrow. Report

Pharma